The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Immune checkpoint blockade in infectious diseases
Open accessAbstract
The upregulation of immune checkpoint molecules, such as programmed cell death protein 1 (PD1) and cytotoxic T lymphocyte antigen 4 (CTLA4), on immune cells occurs during acute infections, such as malaria, as well as during chronic persistent viral infections, including HIV and hepatitis B virus. These pathways are important for preventing immune-driven pathology but can also limit immune-mediated clearance of the infection. The recent success of immune checkpoint blockade in cancer therapy suggests that targeting these pathways would also be effective for preventing and treating a range of infectious diseases. Here, we review our current understanding of immune checkpoint pathways in the pathogenesis of infectious diseases and discuss the potential for therapeutically targeting these pathways in this setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
Rittmeyer, A., Barlesi, F., Waterkamp, D., Park, K., Ciardiello, F., von Pawel, J., Gadgeel, S. M., Hida, T., Kowalski, D. M., Dols, M. C., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32517-x · Cited by 4,675
El-Khoueiry, A. B., Sangro, B., Yau, T., Crocenzi, T. S., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Trojan, J., Welling, T. H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31046-2 · Cited by 4,280
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
Brahmer, J. R., Drake, C. G., Wollner, I., Powderly, J. D., Picus, J., Sharfman, W. H., Stankevich, E., Pons, A., Salay, T. M., McMiller, T. L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7609 · Cited by 2,961
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., et al. (2001) · Nature Immunology · doi:10.1038/85330 · Cited by 2,955
Schweitzer, A., Horn, J., Mikolajczyk, R. T., Krause, G., & Ott, J. J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61412-x · Cited by 2,742
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
Krummel, M. F., & Allison, J. P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.459 · Cited by 2,245
Topalian, S. L., Sznol, M., McDermott, D. F., Kluger, H. M., Carvajal, R. D., Sharfman, W. H., Brahmer, J. R., Lawrence, D. P., Atkins, M. B., Powderly, J. D., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.0105 · Cited by 2,222
Balar, A. V., Galsky, M. D., Rosenberg, J. E., Powles, T., Petrylak, D. P., Bellmunt, J., Loriot, Y., Necchi, A., Hoffman-Censits, J., Perez-Gracia, J. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32455-2 · Cited by 2,199
Kassebaum, N. J., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, J., Carter, A., Casey, D. C., Charlson, F. J., Coates, M. M., Coggeshall, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31460-x · Cited by 2,163
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
Michot, J. M., Bigenwald, C., Champiat, S., Collins, M., Carbonnel, F., Postel-Vinay, S., Berdelou, A., Varga, A., Bahleda, R., Hollebecque, A., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.11.016 · Cited by 2,127
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103
Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation
Anderson, A. C., Joller, N., & Kuchroo, V. K. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.001 · Cited by 2,096
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., & Sharpe, A. H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090847 · Cited by 2,079
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Sakuishi, K., Apetoh, L., Sullivan, J. M., Blazar, B. R., Kuchroo, V. K., & Anderson, A. C. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100643 · Cited by 2,072
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
Zhu, C., Anderson, A. C., Schubart, A., Xiong, H., Imitola, J., Khoury, S. J., Zheng, X. X., Strom, T. B., & Kuchroo, V. K. (2005) · Nature Immunology · doi:10.1038/ni1271 · Cited by 2,057
Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance
Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y., & Sakaguchi, S. (2002) · Nature Immunology · doi:10.1038/ni759 · Cited by 1,729
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Chomont, N., El-Far, M., Ancuta, P., Trautmann, L., Procopio, F. A., Yassine-Diab, B., Boucher, G., Boulassel, M.-R., Ghattas, G., Brenchley, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1972 · Cited by 1,722
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Huang, A. C., Postow, M. A., Orlowski, R. J., Mick, R., Bengsch, B., Manne, S., Xu, W., Harmon, S., Giles, J. R., Wenz, B., et al. (2017) · Nature · doi:10.1038/nature22079 · Cited by 1,664
Woo, S.-R., Turnis, M. E., Goldberg, M. V., Bankoti, J., Selby, M., Nirschl, C. J., Bettini, M. L., Gravano, D. M., Vogel, P., Liu, C. L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1620 · Cited by 1,647
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M.-R., Delwart, E., Sepulveda, H., Balderas, R. S., et al. (2006) · Nature Medicine · doi:10.1038/nm1482 · Cited by 1,565
Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H., & Allison, J. P. (1992) · Nature · doi:10.1038/356607a0 · Cited by 1,559
Yu, X., Harden, K., C Gonzalez, L., Francesco, M., Chiang, E., Irving, B., Tom, I., Ivelja, S., Refino, C. J., Clark, H., et al. (2009) · Nature Immunology · doi:10.1038/ni.1674 · Cited by 1,491
Gamma-Globulin and Acquired Immunity to Human Malaria
COHEN, S., McGREGOR, I. A., & CARRINGTON, S. (1961) · Nature · doi:10.1038/192733a0 · Cited by 1,393
Stanaway, J. D., Flaxman, A. D., Naghavi, M., Fitzmaurice, C., Vos, T., Abubakar, I., Abu-Raddad, L. J., Assadi, R., Bhala, N., Cowie, B., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30579-7 · Cited by 1,358
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.006 · Cited by 1,354
Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
Pauken, K. E., Sammons, M. A., Odorizzi, P. M., Manne, S., Godec, J., Khan, O., Drake, A. M., Chen, Z., Sen, D. R., Kurachi, M., et al. (2016) · Science · doi:10.1126/science.aaf2807 · Cited by 1,348
Role of LAG-3 in Regulatory T Cells
Huang, C.-T., Workman, C. J., Flies, D., Pan, X., Marson, A. L., Zhou, G., Hipkiss, E. L., Ravi, S., Kowalski, J., Levitsky, H. I., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.010 · Cited by 1,325
Chemnitz, J. M., Parry, R. V., Nichols, K. E., June, C. H., & Riley, J. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.945 · Cited by 1,246
Tissue expression of PD-L1 mediates peripheral T cell tolerance
Keir, M. E., Liang, S. C., Guleria, I., Latchman, Y. E., Qipo, A., Albacker, L. A., Koulmanda, M., Freeman, G. J., Sayegh, M. H., & Sharpe, A. H. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051776 · Cited by 1,211
Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
Kamphorst, A. O., Wieland, A., Nasti, T., Yang, S., Zhang, R., Barber, D. L., Konieczny, B. T., Daugherty, C. Z., Koenig, L., Yu, K., et al. (2017) · Science · doi:10.1126/science.aaf0683 · Cited by 1,015
Chen, P.-L., Roh, W., Reuben, A., Cooper, Z. A., Spencer, C. N., Prieto, P. A., Miller, J. P., Bassett, R. L., Gopalakrishnan, V., Wani, K., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1545 · Cited by 988
The epigenetic landscape of T cell exhaustion
Sen, D. R., Kaminski, J., Barnitz, R. A., Kurachi, M., Gerdemann, U., Yates, K. B., Tsao, H.-W., Godec, J., LaFleur, M. W., Brown, F. D., et al. (2016) · Science · doi:10.1126/science.aae0491 · Cited by 986
Brown, J. A., Dorfman, D. M., Ma, F.-R., Sullivan, E. L., Munoz, O., Wood, C. R., Greenfield, E. A., & Freeman, G. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1257 · Cited by 968
Expression of Programmed Death 1 Ligands by Murine T Cells and APC
Yamazaki, T., Akiba, H., Iwai, H., Matsuda, H., Aoki, M., Tanno, Y., Shin, T., Tsuchiya, H., Pardoll, D. M., Okumura, K., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5538 · Cited by 951
Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection
Boni, C., Fisicaro, P., Valdatta, C., Amadei, B., Di Vincenzo, P., Giuberti, T., Laccabue, D., Zerbini, A., Cavalli, A., Missale, G., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02844-06 · Cited by 920
Coinhibitory Pathways in Immunotherapy for Cancer
Baumeister, S. H., Freeman, G. J., Dranoff, G., & Sharpe, A. H. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112049 · Cited by 910
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection
Petrovas, C., Casazza, J. P., Brenchley, J. M., Price, D. A., Gostick, E., Adams, W. C., Precopio, M. L., Schacker, T., Roederer, M., Douek, D. C., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061496 · Cited by 889
B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells
Tseng, S.-Y., Otsuji, M., Gorski, K., Huang, X., Slansky, J. E., Pai, S. I., Shalabi, A., Shin, T., Pardoll, D. M., & Tsuchiya, H. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.7.839 · Cited by 872
Kamphorst, A. O., Pillai, R. N., Yang, S., Nasti, T. H., Akondy, R. S., Wieland, A., Sica, G. L., Yu, K., Koenig, L., Patel, N. T., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705327114 · Cited by 854
Maini, M. K., Boni, C., Lee, C. K., Larrubia, J. R., Reignat, S., Ogg, G. S., King, A. S., Herberg, J., Gilson, R., Alisa, A., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1269 · Cited by 800
Enhancing SIV-specific immunity in vivo by PD-1 blockade
Velu, V., Titanji, K., Zhu, B., Husain, S., Pladevega, A., Lai, L., Vanderford, T. H., Chennareddi, L., Silvestri, G., Freeman, G. J., et al. (2009) · Nature · doi:10.1038/nature07662 · Cited by 771
Zhou, Q., Munger, M. E., Veenstra, R. G., Weigel, B. J., Hirashima, M., Munn, D. H., Murphy, W. J., Azuma, M., Anderson, A. C., Kuchroo, V. K., et al. (2011) · Blood · doi:10.1182/blood-2010-10-310425 · Cited by 675
Bull, P. C., Lowe, B. S., Kortok, M., Molyneux, C. S., Newbold, C. I., & Marsh, K. (1998) · Nature Medicine · doi:10.1038/nm0398-358 · Cited by 645
Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses
Liang, S. C., Latchman, Y. E., Buhlmann, J. E., Tomczak, M. F., Horwitz, B. H., Freeman, G. J., & Sharpe, A. H. (2003) · European Journal of Immunology · doi:10.1002/eji.200324228 · Cited by 639
Sedy, J. R., Gavrieli, M., Potter, K. G., Hurchla, M. A., Lindsley, R. C., Hildner, K., Scheu, S., Pfeffer, K., Ware, C. F., Murphy, T. L., et al. (2005) · Nature Immunology · doi:10.1038/ni1144 · Cited by 632
Romano, E., Kusio-Kobialka, M., Foukas, P. G., Baumgaertner, P., Meyer, C., Ballabeni, P., Michielin, O., Weide, B., Romero, P., & Speiser, D. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417320112 · Cited by 601
Gao, J., Ward, J. F., Pettaway, C. A., Shi, L. Z., Subudhi, S. K., Vence, L. M., Zhao, H., Chen, J., Chen, H., Efstathiou, E., et al. (2017) · Nature Medicine · doi:10.1038/nm.4308 · Cited by 594
Kaufmann, D. E., Kavanagh, D. G., Pereyra, F., Zaunders, J. J., Mackey, E. W., Miura, T., Palmer, S., Brockman, M., Rathod, A., Piechocka-Trocha, A., et al. (2007) · Nature Immunology · doi:10.1038/ni1515 · Cited by 524
Fisicaro, P., Valdatta, C., Massari, M., Loggi, E., Biasini, E., Sacchelli, L., Cavallo, M. C., Silini, E. M., Andreone, P., Missale, G., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.052 · Cited by 488
Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection
Butler, N. S., Moebius, J., Pewe, L. L., Traore, B., Doumbo, O. K., Tygrett, L. T., Waldschmidt, T. J., Crompton, P. D., & Harty, J. T. (2012) · Nature Immunology · doi:10.1038/ni.2180 · Cited by 482
CXCR5+ follicular cytotoxic T cells control viral infection in B cell follicles
Leong, Y. A., Chen, Y., Ong, H. S., Wu, D., Man, K., Deleage, C., Minnich, M., Meckiff, B. J., Wei, Y., Hou, Z., et al. (2016) · Nature Immunology · doi:10.1038/ni.3543 · Cited by 480
Self-citationThe TIGIT/CD226 Axis Regulates Human T Cell Function
Lozano, E., Dominguez-Villar, M., Kuchroo, V., & Hafler, D. A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103627 · Cited by 476
Banga, R., Procopio, F. A., Noto, A., Pollakis, G., Cavassini, M., Ohmiti, K., Corpataux, J.-M., de Leval, L., Pantaleo, G., & Perreau, M. (2016) · Nature Medicine · doi:10.1038/nm.4113 · Cited by 471
TIGIT and CD 96: new checkpoint receptor targets for cancer immunotherapy
Dougall, W. C., Kurtulus, S., Smyth, M. J., & Anderson, A. C. (2017) · Immunological Reviews · doi:10.1111/imr.12518 · Cited by 435
International AIDS Society global scientific strategy: towards an HIV cure 2016
International AIDS Society Towards a Cure Working Group, Deeks, S. G., Lewin, S. R., Ross, A. L., Ananworanich, J., Benkirane, M., Cannon, P., Chomont, N., Douek, D., Lifson, J. D., et al. (2016) · Nature Medicine · doi:10.1038/nm.4108 · Cited by 425
Self-citationCD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART
Fromentin, R., Bakeman, W., Lawani, M. B., Khoury, G., Hartogensis, W., DaFonseca, S., Killian, M., Epling, L., Hoh, R., Sinclair, E., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005761 · Cited by 422
Self-citationFcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis
Dahan, R., Sega, E., Engelhardt, J., Selby, M., Korman, A. J., & Ravetch, J. V. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.08.004 · Cited by 409
Reinvigorating exhausted HIV-specific T cells via PD-1–PD-1 ligand blockade
Freeman, G. J., Wherry, E. J., Ahmed, R., & Sharpe, A. H. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061800 · Cited by 399
Fourcade, J., Sun, Z., Pagliano, O., Guillaume, P., Luescher, I. F., Sander, C., Kirkwood, J. M., Olive, D., Kuchroo, V., & Zarour, H. M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2637 · Cited by 372
Golden-Mason, L., Palmer, B., Klarquist, J., Mengshol, J. A., Castelblanco, N., & Rosen, H. R. (2007) · Journal of Virology · doi:10.1128/jvi.00409-07 · Cited by 371
Fisicaro, P., Barili, V., Montanini, B., Acerbi, G., Ferracin, M., Guerrieri, F., Salerno, D., Boni, C., Massari, M., Cavallo, M. C., et al. (2017) · Nature Medicine · doi:10.1038/nm.4275 · Cited by 341
Programmed death-1 (PD-1)–deficient mice are extraordinarily sensitive to tuberculosis
Lázár-Molnár, E., Chen, B., Sweeney, K. A., Wang, E. J., Liu, W., Lin, J., Porcelli, S. A., Almo, S. C., Nathenson, S. G., & Jacobs, W. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007394107 · Cited by 338
CD4 T Cells Promote Rather than Control Tuberculosis in the Absence of PD-1–Mediated Inhibition
Barber, D. L., Mayer-Barber, K. D., Feng, C. G., Sharpe, A. H., & Sher, A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003304 · Cited by 329
Chew, G. M., Fujita, T., Webb, G. M., Burwitz, B. J., Wu, H. L., Reed, J. S., Hammond, K. B., Clayton, K. L., Ishii, N., Abdel-Mohsen, M., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005349 · Cited by 323
Schurich, A., Khanna, P., Lopes, R. A., Han, K. J., Peppa, D., Micco, L., Nebbia, G., Kennedy, P. T. F., Geretti, A.-M., Dusheiko, G., et al. (2011) · Hepatology · doi:10.1002/hep.24249 · Cited by 307
Zhang, J.-Y., Zhang, Z., Wang, X., Fu, J.-L., Yao, J., Jiao, Y., Chen, L., Zhang, H., Wei, J., Jin, L., et al. (2007) · Blood · doi:10.1182/blood-2006-09-044826 · Cited by 302
The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T‐cell activation
Cai, G., & Freeman, G. J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00783.x · Cited by 301
Nakamoto, N., Kaplan, D. E., Coleclough, J., Li, Y., Valiga, M. E., Kaminski, M., Shaked, A., Olthoff, K., Gostick, E., Price, D. A., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.033 · Cited by 299
Illingworth, J., Butler, N. S., Roetynck, S., Mwacharo, J., Pierce, S. K., Bejon, P., Crompton, P. D., Marsh, K., & Ndungu, F. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202438 · Cited by 294
Bengsch, B., Martin, B., & Thimme, R. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.005 · Cited by 284
Nebbia, G., Peppa, D., Schurich, A., Khanna, P., Singh, H. D., Cheng, Y., Rosenberg, W., Dusheiko, G., Gilson, R., ChinAleong, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047648 · Cited by 276
Four-Year Efficacy of RTS,S/AS01E and Its Interaction with Malaria Exposure
Olotu, A., Fegan, G., Wambua, J., Nyangweso, G., Awuondo, K. O., Leach, A., Lievens, M., Leboulleux, D., Njuguna, P., Peshu, N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1207564 · Cited by 270
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease
Attanasio, J., & Wherry, E. J. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.022 · Cited by 256
Gonzalez, L. C., Loyet, K. M., Calemine-Fenaux, J., Chauhan, V., Wranik, B., Ouyang, W., & Eaton, D. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409071102 · Cited by 252
Liu, J., Zhang, E., Ma, Z., Wu, W., Kosinska, A., Zhang, X., Möller, I., Seiz, P., Glebe, D., Wang, B., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003856 · Cited by 251
Hatano, H., Jain, V., Hunt, P. W., Lee, T.-H., Sinclair, E., Do, T. D., Hoh, R., Martin, J. N., McCune, J. M., Hecht, F., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis630 · Cited by 251
Tuberculosis Treatment and Drug Regimens
Sotgiu, G., Centis, R., D'ambrosio, L., & Migliori, G. B. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017822 · Cited by 241
Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents
Weber, J. S., Postow, M., Lao, C. D., & Schadendorf, D. (2016) · The Oncologist · doi:10.1634/theoncologist.2016-0055 · Cited by 237
Maier, H., Isogawa, M., Freeman, G. J., & Chisari, F. V. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2714 · Cited by 232
Kaufmann, D. E., & Walker, B. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803771 · Cited by 229
Gay, C. L., Bosch, R. J., Ritz, J., Hataye, J. M., Aga, E., Tressler, R. L., Mason, S. W., Hwang, C. K., Grasela, D. M., Ray, N., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix191 · Cited by 224
Molecular pathways: targeting CD96 and TIGIT for cancer immunotherapy
Blake, S. J., Dougall, W. C., Miles, J. J., Teng, M. W. L., & Smyth, M. J. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0933 · Cited by 223
Raziorrouh, B., Schraut, W., Gerlach, T., Nowack, D., Gru¨ ner, N. H., Ulsenheimer, A., Zachoval, R., Wa¨chtler, M., Spannagl, M., Haas, J. R., et al. (2010) · Hepatology · doi:10.1002/hep.23936 · Cited by 214
TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection
Jayaraman, P., Jacques, M. K., Zhu, C., Steblenko, K. M., Stowell, B. L., Madi, A., Anderson, A. C., Kuchroo, V. K., & Behar, S. M. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005490 · Cited by 209
A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors
Chatterjee, S., Lesniak, W. G., Gabrielson, M., Lisok, A., Wharram, B., Sysa-Shah, P., Azad, B. B., Pomper, M. G., & Nimmagadda, S. (2016) · Oncotarget · doi:10.18632/oncotarget.7143 · Cited by 194
Oscillating CD8+ T Cell Effector Functions after Antigen Recognition in the Liver
Isogawa, M., Furuichi, Y., & Chisari, F. V. (2005) · Immunity · doi:10.1016/j.immuni.2005.05.005 · Cited by 186
Hryniewicz, A., Boasso, A., Edghill-Smith, Y., Vaccari, M., Fuchs, D., Venzon, D., Nacsa, J., Betts, M. R., Tsai, W.-P., Heraud, J.-M., et al. (2006) · Blood · doi:10.1182/blood-2006-04-010637 · Cited by 174
Zhang, Z., Zhang, J., Wherry, E. J., Jin, B., Xu, B., Zou, Z., Zhang, S., Li, B., Wang, H., Wu, H., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.037 · Cited by 174
PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status
Sauce, D., Almeida, J. R., Larsen, M., Haro, L., Autran, B., Freeman, G. J., & Appay, V. (2007) · AIDS · doi:10.1097/qad.0b013e3282eee548 · Cited by 174
Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection
Hoffmann, M., Pantazis, N., Martin, G. E., Hickling, S., Hurst, J. M., Meyerowitz, J., Willberg, C. B., Robinson, N., Brown, H. L., Fisher, M., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005661 · Cited by 173
Youngblood, B., Noto, A., Porichis, F., Akondy, R. S., Ndhlovu, Z. M., Austin, J. W., Bordi, R., Procopio, F. A., Miura, T., Allen, T. M., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203161 · Cited by 171
Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
Hurst, J., Hoffmann, M., Pace, M., Williams, J. P., Thornhill, J., Hamlyn, E., Meyerowitz, J., Willberg, C., Koelsch, K. K., Robinson, N., et al. (2015) · Nature Communications · doi:10.1038/ncomms9495 · Cited by 170
Global strategies are required to cure and eliminate HBV infection
Revill, P., Testoni, B., Locarnini, S., & Zoulim, F. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.7 · Cited by 167
Esch, K. J., Juelsgaard, R., Martinez, P. A., Jones, D. E., & Petersen, C. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301810 · Cited by 166
Tian, X., Zhang, A., Qiu, C., Wang, W., Yang, Y. Z., Qiu, C., Liu, A., Zhu, L., Yuan, S., Hu, H., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402176 · Cited by 164
Bhadra, R., Gigley, J. P., Weiss, L. M., & Khan, I. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015298108 · Cited by 163
PD-1 Dependent Exhaustion of CD8+ T Cells Drives Chronic Malaria
Horne‐Debets, J. M., Faleiro, R. J., Karunarathne, D. S., Liu, X. Q., Lineburg, K. E., Poh, C. M., Grotenbreg, G. M., Hill, G. R., MacDonald, K. P. A., Good, M. F., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.11.002 · Cited by 163
Self-citationRegulation of T cell activation and tolerance by PDL2
Zhang, Y., Chung, Y., Bishop, C., Daugherty, B., Chute, H., Holst, P., Kurahara, C., Lott, F., Sun, N., Welcher, A. A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601347103 · Cited by 159
Shin, T., Kennedy, G., Gorski, K., Tsuchiya, H., Koseki, H., Azuma, M., Yagita, H., Chen, L., Powell, J., Pardoll, D., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030242 · Cited by 159
In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses
Shin, T., Yoshimura, K., Shin, T., Crafton, E. B., Tsuchiya, H., Housseau, F., Koseki, H., Schulick, R. D., Chen, L., & Pardoll, D. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050072 · Cited by 159
Joshi, T., Rodriguez, S., Perovic, V., Cockburn, I. A., & Stäger, S. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000431 · Cited by 158
Shetty, R. D., Velu, V., Titanji, K., Bosinger, S. E., Freeman, G. J., Silvestri, G., & Amara, R. R. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60612 · Cited by 158
Gene-targeted mice lacking B cells are unable to eliminate a blood stage malaria infection
von der Weid, T., Honarvar, N., & Langhorne, J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.7.2510 · Cited by 155
Host–virus interactions in hepatitis B virus infection
Guidotti, L. G., Isogawa, M., & Chisari, F. V. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.06.016 · Cited by 151
Podoba, J. E., & Stevenson, M. M. (1991) · Infection and Immunity · doi:10.1128/iai.59.1.51-58.1991 · Cited by 148
Effect of ipilimumab on the HIV reservoir in an HIV-infected individual with metastatic melanoma
Wightman, F., Solomon, A. E., Kumar, S. S., Urriola, N., Gallagher, K. J., Hiener, B. M., Palmer, S., McNeil, C. M., Garsia, R. J., & Lewin, S. R. (2015) · AIDS · doi:10.1097/qad.0000000000000562 · Cited by 143
Self-citationRutigliano, J. A., Sharma, S., Morris, M. Y., Oguin, T. H., McClaren, J. L., Doherty, P. C., & Thomas, P. G. (2013) · Journal of Virology · doi:10.1128/jvi.02851-13 · Cited by 138
Mitsui, J., Nishikawa, H., Muraoka, D., Wang, L., Noguchi, T., Sato, E., Kondo, S., Allison, J. P., Sakaguchi, S., Old, L. J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3243 · Cited by 135
Hafalla, J. C. R., Claser, C., Couper, K. N., Grau, G. E., Rénia, L., de Souza, J. B., & Riley, E. M. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002504 · Cited by 131
Urbani, S., Amadei, B., Tola, D., Pedrazzi, G., Sacchelli, L., Cavallo, M. C., Orlandini, A., Missale, G., & Ferrari, C. I. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.12.014 · Cited by 128
Cecchinato, V., Tryniszewska, E. A., Ma, Z. M., Vaccari, M., Boasso, A., Tsai, W.-P., Petrovas, C., Fuchs, D., Héraud, J., Venzon, D. J., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5439 · Cited by 127
Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection
Mylvaganam, G., Ríos, D., Abdelaal, H. M., Iyer, S. S., Tharp, G. K., Mavigner, M., Hicks, S. L., Chahroudi, A., Ahmed, R., Bosinger, S. E., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621418114 · Cited by 122
Programmed death-1 expression on CD4+ and CD8+ T cells in treated and untreated HIV disease
Cockerham, L. R., Jain, V., Sinclair, E., Glidden, D. V., Hartogenesis, W., Hatano, H., Hunt, P. W., Martin, J. N., Pilcher, C. D., Sékaly, R., et al. (2014) · AIDS · doi:10.1097/qad.0000000000000314 · Cited by 121
Modulation of T reg cells/ T effector function by GITR signaling is context–dependent
Ephrem, A., Epstein, A. L., Stephens, G. L., Thornton, A. M., Glass, D. D., & Shevach, E. M. (2013) · European Journal of Immunology · doi:10.1002/eji.201343451 · Cited by 115
Sharma, S., Sundararajan, A., Suryawanshi, A. S., Kumar, N., Veiga‐Parga, T., Kuchroo, V. K., Thomas, P. G., Sangster, M. Y., & Rouse, B. T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107087108 · Cited by 112
Moreno, B. H., Mok, S., Comin-Anduix, B., Hu‐Lieskovan, S., & Ribas, A. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1052212 · Cited by 105
Karunarathne, D. S., Horne‐Debets, J. M., Huang, J. X., Faleiro, R. J., Leow, C. Y., Amante, F. H., Watkins, T. S., Miles, J. J., Dwyer, P., Stacey, K. J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.017 · Cited by 104
Self-citationKhoury, G., Fromentin, R., Solomon, A. E., Hartogensis, W., Killian, M. L., Hoh, R., Somsouk, M., Hunt, P. W., Girling, V., Sinclair, E., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix039 · Cited by 103
Self-citationZander, R., Obeng-Adjei, N., Guthmiller, J. J., Kulu, D., Li, J., Ongoïba, A., Traoré, B., Crompton, P. D., & Butler, N. S. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.03.007 · Cited by 99
Demethylation of the PD-1 Promoter Is Imprinted during the Effector Phase of CD8 T Cell Exhaustion
Ahn, E., Youngblood, B., Lee, J., Lee, J., Sarkar, S., & Ahmed, R. (2016) · Journal of Virology · doi:10.1128/jvi.00798-16 · Cited by 98
Tousif, S., Singh, Y., Prasad, D. V. R., Sharma, P., Kaer, L. V., & Das, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019864 · Cited by 93
Artemisinin resistance in Plasmodium falciparum: A process linked to dormancy?
Cheng, Q., Kyle, D. E., & Gatton, M. L. (2012) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2012.01.001 · Cited by 93
Plasmodium yoelii Can Ablate Vaccine-Induced Long-Term Protection in Mice
Wykes, M., Zhou, Y.-H., Liu, X. Q., & Good, M. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2510 · Cited by 88
Self-citationRaziorrouh, B., Heeg, M. H. J., Kurktschiev, P., Schraut, W., Zachoval, R., Clemens, W., Wächtler, M., Spannagl, M., Denk, G., Ulsenheimer, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105703 · Cited by 78
World Malaria Day 2009: What Malaria Knows about the Immune System That Immunologists Still Do Not
Pierce, S. K., & Miller, L. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804153 · Cited by 77
Tauriainen, J., Scharf, L., Frederiksen, J., Naji, A., Ljunggren, H., Sönnerborg, A. B., Lund, O., Reyes‐Terán, G., Hecht, F. M., Deeks, S. G., et al. (2017) · Scientific Reports · doi:10.1038/srep40354 · Cited by 74
PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice
Zhou, J., Cheung, A. K. L., Tan, Z., Wang, H., Yu, W., Du, Y., Kang, Y., Lu, X., Liu, L., Yuen, K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64704 · Cited by 73
Li, S., Folkvord, J. M., Rakasz, E. G., Abdelaal, H. M., Wagstaff, R. K., Kovács, K. J., Kim, H. O., Sawahata, R., MaWhinney, S., Masopust, D., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01332-16 · Cited by 73
Role of T‐Cell Dysfunction, Inflammation, and Coagulation in Microvascular Disease in HIV
Sinha, A., Ma, Y., Scherzer, R., Hur, S., Li, D., Ganz, P., Deeks, S. G., & Hsue, P. Y. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004243 · Cited by 68
Shive, C. L., Clagett, B. M., McCausland, M. R., Mudd, J. C., Funderburg, N., Freeman, M. L., Younes, S., Ferrari, B., Rodriguez, B. A., McComsey, G. A., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000913 · Cited by 66
PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing
Akhmetzyanova, I., Drabczyk-Pluta, M., Neff, C. P., Sutter, K., Dietze, K. K., Werner, T., Liu, J., Chen, L., Lang, K. S., Palmer, B. E., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005224 · Cited by 64
Lukens, J. R., Cruise, M. W., Lassen, M. G., & Hahn, Y. S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4875 · Cited by 62
Barragán, A., Kremsner, P. G., Weiss, W. R., Wahlgren, M., & Carlson, J. (1998) · Infection and Immunity · doi:10.1128/iai.66.10.4783-4787.1998 · Cited by 59
A New VISTA on combination therapy for negative checkpoint regulator blockade
Deng, J., Mercier, I. L., Kuta, A., & Noelle, R. J. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0190-5 · Cited by 57
Chang, J. J., Thompson, A. J. V., Visvanathan, K., Kent, S. J., Cameron, P. U., Wightman, F., Desmond, P. V., LOCARNINI, S. A., & Lewin, S. R. (2007) · Hepatology · doi:10.1002/hep.21844 · Cited by 52
Self-citationLigation of B and T Lymphocyte Attenuator Prevents the Genesis of Experimental Cerebral Malaria
Lepenies, B., Pfeffer, K., Hurchla, M. A., Murphy, T. L., MURPHY, K. M. M., Oetzel, J., Fleischer, B., & Jacobs, T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.4093 · Cited by 48
Kelesidis, T., Jackson, N. M., McComsey, G. A., Wang, X., Elashoff, D. A., Dubé, M. P., Brown, T. T., Yang, O. O., Stein, J. H., & Currier, J. S. (2016) · AIDS · doi:10.1097/qad.0000000000001238 · Cited by 47
Mou, Z., Muleme, H. M., Liu, D., Jia, P., Okwor, I., Kuriakose, S. M., Beverley, S. M., & Uzonna, J. E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202537 · Cited by 45
Premunition against Plasmodium falciparum in a malaria hyperendemic village in Myanmar
Soe-Soe, Khin-Saw-Aye, Htay-Aung, Nay-Win, Tin-Aung, Than-Swe, Roussilhion, C., Pérignon, J., & Druilhe, P. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90342-6 · Cited by 44
Zhang, E., Zhang, X., Liu, J., Wang, B., Tian, Y., Kosinska, A. D., Ma, Z., Xu, Y. Y., Dittmer, U., Roggendorf, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026196 · Cited by 43
Hatano, H., Scherzer, R., Wu, Y., Harvill, K., Maka, K., Hoh, R., Sinclair, E., Palmer, S., Martin, J. N., Busch, M. P., et al. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31826e7d0f · Cited by 40
Boer, M. C., van Meijgaarden, K. E., Goletti, D., Vanini, V., Prins, C., Ottenhoff, T. H. M., & Joosten, S. A. (2015) · Tuberculosis · doi:10.1016/j.tube.2015.11.008 · Cited by 38
Liu, X. Q., Stacey, K. J., Horne‐Debets, J. M., Cridland, J. A., Fischer, K., Narum, D. L., Mackay, F., Pierce, S. K., & Wykes, M. (2012) · European Journal of Immunology · doi:10.1002/eji.201242689 · Cited by 37
Self-citationAnti-GITR antibodies--potential clinical applications for tumor immunotherapy.
Schaer, D., Cohen, A. D., & Wolchok, J. D. (2010) · PubMed · Cited by 35
Hisaeda, H., Hamano, S., Obata, C., Tetsutani, K., Imai, T., Waldmann, H., Himeno, K., & Yasutomo, K. (2005) · European Journal of Immunology · doi:10.1002/eji.200526073 · Cited by 32
Pollock, K. M., Montamat‐Sicotte, D., Grass, L., Cooke, G., Kapembwa, M. S., Kon, O. M., Sampson, R. D., Taylor, G. P., & Lalvani, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146905 · Cited by 32
Gill, A. L., Green, S. A., Abdullah, S. A. A., Saout, C. L., Pittaluga, S., Chen, H., Turnier, R., Lifson, J. D., Godin, S., Qin, J., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001217 · Cited by 32
Wang, H., Wu, B., Li, L., Hu, L., Lin, J., Jiang, C., Cai, G., & Shen, Q. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2016.10.002 · Cited by 32
Xu, D., Fu, H.-H., Obar, J., Park, J.-J., Tamada, K., Yagita, H., & Lefrançois, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056539 · Cited by 28
Down-Regulation of CTLA-4 by HIV-1 Nef Protein
Far, M. E., Isabelle, C., Chomont, N., Bourbonnière, M., Fonseca, S. G., Ancuța, P., Peretz, Y., Chouikh, Y., Halwani, R., Schwartz, O., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054295 · Cited by 28
Horne‐Debets, J. M., Karunarathne, D. S., Faleiro, R. J., Poh, C. M., Rénia, L., & Wykes, M. (2016) · Scientific Reports · doi:10.1038/srep26210 · Cited by 27
Self-citationRutishauser, R. L., Hartogensis, W., Deguit, C. D. T., Krone, M., Hoh, R., Hecht, F. M., Pilcher, C. D., Bacchetti, P., Deeks, S. G., Hunt, P. W., et al. (2017) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2016.0324 · Cited by 27
Cancer therapies in HIV cure research
Rasmussen, T. A., Anderson, J. L., Wightman, F., & Lewin, S. R. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000328 · Cited by 23
Self-citationFar, M. E., Ancuța, P., Routy, J., Zhang, Y., Bakeman, W., Bordi, R., DaFonseca, S., Said, E. A., Gosselin, A., Tep, T.-S., et al. (2015) · Journal of General Virology · doi:10.1099/vir.0.000065 · Cited by 17
Cited by
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
Morad, G., Helmink, B. A., Sharma, P., & Wargo, J. A. (2021) · Cell · doi:10.1016/j.cell.2021.09.020 · Cited by 1,648
Immune checkpoint inhibitors in melanoma
Carlino, M. S., Larkin, J., & Long, G. V. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01206-x · Cited by 1,185
Beltra, J.-C., Manne, S., Abdel-Hakeem, M. S., Kurachi, M., Giles, J. R., Chen, Z., Casella, V., Ngiow, S. F., Khan, O., Huang, Y. J., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.014 · Cited by 1,082
Sun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,014
The Balance of Th17 versus Treg Cells in Autoimmunity
Lee, G. R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030730 · Cited by 857
Metadata
- Authors
- Wykes, M. N., & Lewin, S. R.
- Venue
- Nature Reviews Immunology
- Published
- 2017-10-09
- Volume
- 18
- Issue
- 2
- Pages
- 91-104
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2761099324
- Cited by
- 570
- References
- 166
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.